Tctc Holdings, LLC Abbott Laboratories Transaction History

Tctc Holdings, LLC

$2.88 Billion
Q3 2024

A detailed history of Tctc Holdings, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Tctc Holdings, LLC holds 102,912 shares of ABT stock, worth $12.1 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

102,912

Previous 103,385 0.46%

Holding current value

$12.1 Million

Previous $10.7 Million 9.22%

% of portfolio

0.41%

Previous 0.38%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $47,333 - $55,875	-473 Reduced 0.46%	102,912 $11.7 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $179,299 - $200,143	-1,780 Reduced 1.69%	103,385 $10.7 Million
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $185,636 - $205,027	-1,695 Reduced 1.59%	105,165 $12 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $34,091 - $41,731	378 Added 0.35%	106,860 $11.8 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $66,393 - $79,660	-695 Reduced 0.65%	106,482 $10.3 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $16,427 - $18,303	163 Added 0.15%	107,177 $11.7 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $281,378 - $331,199	2,905 Added 2.79%	107,014 $10.8 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $25,095 - $29,441	264 Added 0.25%	104,109 $11.4 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $102,952 - $119,199	-1,064 Reduced 1.01%	103,845 $10 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $754,195 - $911,580	-7,389 Reduced 6.58%	104,909 $11.4 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $97,943 - $119,435	-859 Reduced 0.76%	112,298 $13.3 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $14,441 - $17,682	-125 Reduced 0.11%	113,157 $15.9 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $110,593 - $122,348	-948 Reduced 0.83%	113,282 $13.4 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $203,751 - $239,844	-1,926 Reduced 1.66%	114,230 $13.2 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $11.6 Million - $13.7 Million	106,881 Added 1152.36%	116,156 $13.9 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $11 Million - $11.9 Million	-104,426 Reduced 91.84%	9,275 $1.02 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $171,183 - $207,889	1,868 Added 1.67%	113,701 $12.4 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $176,034 - $225,302	-2,299 Reduced 2.01%	111,833 $10.2 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $190,344 - $278,335	-3,030 Reduced 2.59%	114,132 $9.01 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $23,553 - $26,220	300 Added 0.26%	117,162 $10.2 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $237,336 - $257,345	-2,900 Reduced 2.42%	116,862 $9.78 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $127,539 - $148,750	-1,750 Reduced 1.44%	119,762 $10.1 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $8,939 - $10,808	-135 Reduced 0.11%	121,512 $9.71 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $12,390 - $14,037	189 Added 0.16%	121,647 $8.8 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $18,243 - $22,008	-300 Reduced 0.25%	121,458 $8.91 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $28,785 - $31,770	-500 Reduced 0.41%	121,758 $7.43 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $25,321 - $28,629	450 Added 0.37%	122,258 $7.33 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $50,996 - $54,596	-950 Reduced 0.77%	121,808 $6.95 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $48,108 - $53,693	-1,001 Reduced 0.81%	122,758 $6.55 Million
Q2 2017 Aug 14, 2017	BUY	N/A	123,759	123,759 $6.02 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tctc Holdings, LLC with notifications on news.

Account

Tctc Holdings, LLC Abbott Laboratories Transaction History